Ib A. Jacobsen
Sdr. Boulevard 29
Odense C, 5000, Denmark
Odense C, 5000, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Amiloride lowers plasma TNF and interleukin-6 but not interleukin-17A in patients with hypertension and type 2 diabetes.
Journal: American journal of physiology. Renal physiology
Published: May 23, 2024
Comprehensive analysis of failure to carry out successful genomic profiling in a phase I setting.
Journal: ESMO open
Published: January 11, 2024
Renal Artery Stenting in Consecutive High-Risk Patients With Atherosclerotic Renovascular Disease: A Prospective 2-Center Cohort Study.
Journal: Journal of the American Heart Association
Published: March 24, 2022
The mineralocorticoid receptor blocker spironolactone lowers plasma interferon-γ and interleukin-6 in patients with type 2 diabetes and treatment-resistant hypertension.
Journal: Journal of hypertension
Published: November 29, 2021
Baseline urinary metabolites predict albuminuria response to spironolactone in type 2 diabetes.
Journal: Translational research : the journal of laboratory and clinical medicine
Published: September 18, 2019
The acute blood pressure-lowering effect of amiloride is independent of endothelial ENaC and eNOS in humans and mice.
Journal: Acta physiologica (Oxford, England)
Published: January 05, 2018
Albuminuria is associated with an increased prostasin in urine while aldosterone has no direct effect on urine and kidney tissue abundance of prostasin.
Journal: Pflugers Archiv : European journal of physiology
Published: November 17, 2016
Predicting albuminuria response to spironolactone treatment with urinary proteomics in patients with type 2 diabetes and hypertension.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: June 26, 2016
Amiloride lowers blood pressure and attenuates urine plasminogen activation in patients with treatment-resistant hypertension.
Journal: Journal of the American Society of Hypertension : JASH
Published: July 12, 2014
Selective renal vasoconstriction, exaggerated natriuresis and excretion rates of exosomic proteins in essential hypertension.
Journal: Acta physiologica (Oxford, England)
Published: April 05, 2014
Low-dose spironolactone reduces plasma fibulin-1 levels in patients with type 2 diabetes and resistant hypertension.
Journal: Journal of human hypertension
Published: November 12, 2013
Last Updated: 09/26/2026